LFMDPHIGH SIGNALOPERATIONAL10-K

LFMDP divested its majority-owned subsidiary WorkSimpli on November 4, 2025, which appears to have significantly improved the company's financial position.

The divestiture of WorkSimpli represents a major strategic shift that allowed management to streamline operations and focus on their core telehealth business. The sale appears to have provided substantial proceeds that helped eliminate the negative stockholders' equity position and reduce debt burden, positioning the company for improved financial stability.

Comparing 2026-03-10 vs 2025-03-11View on EDGAR →
FINANCIAL ANALYSIS

LFMDP showed dramatic financial improvement with net income swinging from a $18.9M loss to $14.4M profit (+176%) while revenue grew 49.8% to $12.5M, indicating strong operational momentum in their core telehealth business. The balance sheet strengthened significantly with stockholders' equity improving from negative $5.5M to positive $23.2M (+522%) and total liabilities decreasing 38.2% to $47.3M, largely driven by the WorkSimpli divestiture proceeds. However, operating cash flow declined 52.7% to $8.3M, suggesting the positive net income may include one-time gains from the asset sale rather than purely operational improvements.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+522.1%
-$5.5M$23.2M

Equity base grew 522.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Share Buybacks
Cash Flow
+252.3%
$77K$270K

Share repurchases increased 252.3% — management returning capital, signals confidence in intrinsic value.

Net Income
P&L
+176%
-$18.9M$14.4M

Net income grew 176% — bottom-line growth signals improving overall business health.

Operating Cash Flow
Cash Flow
-52.7%
$17.5M$8.3M

Operating cash flow fell 52.7% — earnings quality concerns; investigate working capital changes and non-cash items.

Operating Income
P&L
+52.5%
-$16.1M-$7.7M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Revenue
P&L
+49.8%
$8.3M$12.5M

Strong top-line growth of 49.8% — accelerating demand or successful expansion into new markets.

Total Liabilities
Balance Sheet
-38.2%
$76.5M$47.3M

Liabilities reduced 38.2% — deleveraging improves balance sheet strength and financial flexibility.

Interest Expense
P&L
-37.6%
$2.2M$1.4M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Current Liabilities
Balance Sheet
-31%
$60.3M$41.6M

Current liabilities reduced — improved short-term financial position and working capital health.

Capital Expenditure
Cash Flow
+25.5%
$1.5M$1.9M

Capex increased 25.5% — ongoing investment in capacity or infrastructure for future growth.

LANGUAGE CHANGES
NEW — 2026-03-10
PRIOR — 2025-03-11
ADDED
Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission ( SEC ).
(formerly known as Conversion Labs, Inc.), and LifeMD Pharmacy Holdings LLC, an affiliated limited liability company, ( LifeMD Pharmacy ).
On November 4, 2025, we sold our interest in our majority-owned subsidiary WorkSimpli Software LLC (formerly known as LegalSimpli Software, LLC), a Puerto Rico limited liability company ( WorkSimpli ) to Lion Buyer, LLC.
WorkSimpli is classified as discontinued operations for all periods presented in these consolidated financial statements included in this Annual Report on Form 10-K.
BUSINESS Business Overview LifeMD is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services.
+7 more — sign up free →
REMOVED
Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission ( SEC ), including the risk factors identified in Item 1A of this report.
(formerly known as Conversion Labs, Inc.), LifeMD Pharmacy Holdings LLC, an affiliated limited liability company, ( LifeMD Pharmacy ) and our majority-owned subsidiary WorkSimpli Software LLC (formerly known as LegalSimpli Software, LLC), a Puerto Rico limited liability company ( WorkSimpli ).
BUSINESS Business Overview We are a direct-to-patient telehealth company providing a high-quality, cost-effective, and convenient way to access comprehensive, virtual and in-home healthcare.
We believe the traditional model of visiting a doctor s office, traveling to a retail pharmacy, and returning for follow-up care or prescription refills is complex, inefficient, and costly which discourages many individuals from seeking much-needed medical care.
LifeMD is improving the delivery of the healthcare experience through telehealth with our proprietary technology platform, affiliated and dedicated provider network, broad and expanding treatment capabilities, and the unique ability to nurture patient relationships.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →